Nanjing Gator Meditech Company, Ltd.;Iwanowicz, Edwin, J.
发明人:
IWANOWICZ, Edwin, J.
申请号：
EP17840401
公开号：
EP3496724A4
申请日:
2017.08.14
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Novel compounds and pharmaceutically acceptable salts capable of modulating the activity of kinases, including Akt, ERK and MEK. Such modulation affects biological functions, for example, by inhibiting cell proliferation and/or inducing apoptosis. Also provided are pharmaceutical compositions and medicaments, comprising the compounds or salts of the invention, alone or in combination with other therapeutic agents or palliative agents.
